The Food and Drug Administration (FDA) is working to revamp its guidance on the naming, labeling and packaging of medications. The agency is committed to publishing new guidance by Sept. 30 in an effort to reduce medication errors. According to the FDA, nearly 30 percent of medication errors can be credited to packaging and labeling issues. Frequent sources of errors include look-alike or sound-alike names, modifier omission or oversight, encoded numerals, failure to recognize the active ingredient, dangerous abbreviations and medical abbreviations, and the length of names. more

Forgot Your Password?

Not a member? Join now!